Status:

NOT_YET_RECRUITING

Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study

Lead Sponsor:

Copenhagen University Hospital, Hvidovre

Conditions:

Asthma

Eligibility:

FEMALE

18-75 years

Brief Summary

The project aims to investigate the effect of female sex hormone treatment (both contraceptive treatment and hormone therapy during menopause) on bronchial hyperreactivity in adult women. The study is...

Eligibility Criteria

Inclusion

  • Women aged 18 to 75 years
  • Planning to initiate HRT/HC within next 30 days

Exclusion

  • Gynecological, endocrinological or other disease affecting the ovarian cycle
  • FEV1 \< 60% of expected or \< 1.5L
  • Current hormonal medication
  • Pregnancy

Key Trial Info

Start Date :

September 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT06578169

Start Date

September 1 2024

End Date

September 1 2027

Last Update

August 29 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study | DecenTrialz